DD127381A5 - - Google Patents
Info
- Publication number
- DD127381A5 DD127381A5 DD194650A DD19465076A DD127381A5 DD 127381 A5 DD127381 A5 DD 127381A5 DD 194650 A DD194650 A DD 194650A DD 19465076 A DD19465076 A DD 19465076A DD 127381 A5 DD127381 A5 DD 127381A5
- Authority
- DD
- German Democratic Republic
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP50108197A JPS5231821A (en) | 1975-09-05 | 1975-09-05 | Method of manufacturing freeze-dried dehydroepiandrosterone sulfate sa lts for injection use |
| JP8061376A JPS537662A (en) | 1976-07-06 | 1976-07-06 | Preparation of injection containing stable dehydroepiandrosterone sulfate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD127381A5 true DD127381A5 (en:Method) | 1977-09-21 |
Family
ID=26421606
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD194650A DD127381A5 (en:Method) | 1975-09-05 | 1976-09-06 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US4061744A (en:Method) |
| AU (1) | AU498543B2 (en:Method) |
| CA (1) | CA1047404A (en:Method) |
| CS (1) | CS216160B2 (en:Method) |
| DD (1) | DD127381A5 (en:Method) |
| DE (1) | DE2639849C2 (en:Method) |
| DK (1) | DK153124C (en:Method) |
| ES (1) | ES451256A1 (en:Method) |
| FR (1) | FR2322605A1 (en:Method) |
| GB (1) | GB1561360A (en:Method) |
| HU (1) | HU173475B (en:Method) |
| IL (1) | IL50376A (en:Method) |
| NL (1) | NL183385C (en:Method) |
| SE (1) | SE439586B (en:Method) |
| SU (1) | SU1072789A3 (en:Method) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4496556A (en) * | 1982-08-16 | 1985-01-29 | Norman Orentreich | Topical applications for preventing dry skin |
| GB8403360D0 (en) * | 1984-02-08 | 1984-03-14 | Erba Farmitalia | Pharmaceutical compositions |
| JPS63104924A (ja) * | 1986-10-20 | 1988-05-10 | Kanebo Ltd | 膣坐剤 |
| NL194728C (nl) * | 1987-04-16 | 2003-01-07 | Hollis Eden Pharmaceuticals | Farmaceutisch preparaat geschikt voor de profylaxe of therapie van een retrovirale infectie of een complicatie of gevolg daarvan. |
| JPS6440428A (en) * | 1987-08-07 | 1989-02-10 | Daiichi Yakuhin Sangyo Kk | Antihyperlipemia |
| JP2546808B2 (ja) * | 1989-01-23 | 1996-10-23 | 鐘紡株式会社 | 膣坐剤 |
| US5246704A (en) * | 1989-01-23 | 1993-09-21 | Kanebo, Ltd. | Vaginal suppository |
| US5004651A (en) * | 1989-01-24 | 1991-04-02 | Abbott Laboratories | Stabilizing system for solid dosage forms |
| CA2013474C (en) * | 1989-04-20 | 2000-01-18 | Pharmacia Inc. | Cyclophosphamide - alanine lyophilizates |
| US5268368A (en) * | 1991-05-17 | 1993-12-07 | Erbamont, Inc. | Cyclophosphamide--amino acid lyophilizates |
| US5210081A (en) * | 1992-02-26 | 1993-05-11 | American Home Products Corporation | Alkali metal 8,9-dehydroestrone sulfate esters |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB957392A (en) * | 1961-07-17 | 1964-05-06 | Farmaceutici Italia | 16ª-hydroxy-steroids |
| DE1767898A1 (de) * | 1967-07-28 | 1971-09-30 | Hoffmann La Roche | Verfahren zur Herstellung einer Arzneimittelzubereitung |
| US4005200A (en) * | 1975-07-17 | 1977-01-25 | Kanebo, Ltd. | Method for improving the maturity of the parturient canal and the sensitivity to oxytocin |
-
1976
- 1976-08-26 SE SE7609443A patent/SE439586B/xx unknown
- 1976-08-27 GB GB35659/76A patent/GB1561360A/en not_active Expired
- 1976-08-30 IL IL50376A patent/IL50376A/xx unknown
- 1976-08-31 US US05/719,278 patent/US4061744A/en not_active Expired - Lifetime
- 1976-09-02 DK DK396576A patent/DK153124C/da not_active IP Right Cessation
- 1976-09-03 DE DE2639849A patent/DE2639849C2/de not_active Expired
- 1976-09-03 CS CS765741A patent/CS216160B2/cs unknown
- 1976-09-03 SU SU762395947A patent/SU1072789A3/ru active
- 1976-09-03 HU HU76KA1471A patent/HU173475B/hu unknown
- 1976-09-03 CA CA260,475A patent/CA1047404A/en not_active Expired
- 1976-09-03 NL NLAANVRAGE7609833,A patent/NL183385C/xx not_active IP Right Cessation
- 1976-09-04 ES ES451256A patent/ES451256A1/es not_active Expired
- 1976-09-06 DD DD194650A patent/DD127381A5/xx unknown
- 1976-09-06 AU AU17486/76A patent/AU498543B2/en not_active Expired
- 1976-09-06 FR FR7626734A patent/FR2322605A1/fr active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| CA1047404A (en) | 1979-01-30 |
| FR2322605B1 (en:Method) | 1982-08-20 |
| GB1561360A (en) | 1980-02-20 |
| IL50376A0 (en) | 1976-10-31 |
| US4061744A (en) | 1977-12-06 |
| CS216160B2 (en) | 1982-10-29 |
| AU1748676A (en) | 1978-03-16 |
| NL183385B (nl) | 1988-05-16 |
| SE439586B (sv) | 1985-06-24 |
| SE7609443L (sv) | 1977-03-06 |
| DE2639849A1 (de) | 1977-03-17 |
| AU498543B2 (en) | 1979-03-15 |
| IL50376A (en) | 1979-10-31 |
| DK153124B (da) | 1988-06-20 |
| NL7609833A (nl) | 1977-03-08 |
| DK396576A (da) | 1977-03-06 |
| DK153124C (da) | 1988-12-19 |
| ES451256A1 (es) | 1977-09-16 |
| DE2639849C2 (de) | 1987-02-12 |
| NL183385C (nl) | 1988-10-17 |
| SU1072789A3 (ru) | 1984-02-07 |
| HU173475B (hu) | 1979-05-28 |
| FR2322605A1 (fr) | 1977-04-01 |